{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T22:32:13Z","timestamp":1780612333090,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ijcard.2016.05.008","type":"journal-article","created":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T00:39:32Z","timestamp":1463186372000},"page":"312-317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Erythropoietin improves cardiac wasting and outcomes in a rat model of liver cancer cachexia"],"prefix":"10.1016","volume":"218","author":[{"given":"Masakazu","family":"Saitoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiyoshi","family":"Hatanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Palus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Ebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"D\u00f6hner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"von Haehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Springer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.05.008_bb0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1040-8428(87)80003-3","article-title":"Cancer cachexia","volume":"7","author":"Norton","year":"1987","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ijcard.2016.05.008_bb0010","doi-asserted-by":"crossref","first-page":"182872","DOI":"10.1155\/2015\/182872","article-title":"Nonmuscle tissues contribution to cancer cachexia","volume":"2015","author":"Argil\u00e9s","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ijcard.2016.05.008_bb0015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13539-014-0137-y","article-title":"Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist","volume":"5","author":"Kazemi-Bajestani","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2016.05.008_bb0020","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jacc.2014.07.948","article-title":"Cardiovascular function and predictors of exercise capacity in patients with colorectal cancer","volume":"64","author":"Cramer","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.05.008_bb0025","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/eurheartj\/eht302","article-title":"Prevention of liver cancer cachexia-induced cardiac wasting and heart failure","volume":"35","author":"Springer","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.05.008_bb0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1365-2354.2001.00264.x","article-title":"Improvement in quality of life for cancer patients treated with epoetin alfa","volume":"10","author":"Libretto","year":"2001","journal-title":"Eur. J. Cancer Care"},{"key":"10.1016\/j.ijcard.2016.05.008_bb0035","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1200\/JCO.2001.19.21.4126","article-title":"Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemo- therapy","volume":"19","author":"Quirt","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijcard.2016.05.008_bb0040","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.ejca.2004.06.019","article-title":"The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients","volume":"40","author":"Ludwig","year":"2004","journal-title":"Eur. J. Cancer"},{"issue":"Suppl. 2","key":"10.1016\/j.ijcard.2016.05.008_bb0045","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ctrv.2006.04.007","article-title":"European Organisation for Research and Treatment of Cancer. European guidelines for the management of chemotherapy-induced anaemia and health economic aspects of treatment","volume":"32","author":"Repetto","year":"2006","journal-title":"Cancer Treat. Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2016.05.008_bb0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1634\/theoncologist.2009-S1-6","article-title":"Update on erythropoiesis-stimulating agents and clinical trials in oncology","volume":"14","author":"Aapro","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.ijcard.2016.05.008_bb0055","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1194\/jlr.M038406","article-title":"Erythropoietin administration partially prevents adipose tissue loss in experimental cancer cachexia models","volume":"54","author":"Penna","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijcard.2016.05.008_bb0060","first-page":"29","article-title":"Skeletal muscle alterations and exercise performance decrease in erythropoietin-deficient mice: a comparative study","volume":"5","author":"Mille-Hamard","year":"2012","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.ijcard.2016.05.008_bb0065","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.cardiores.2006.05.010","article-title":"Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia\/reperfusion","volume":"71","author":"Tada","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2016.05.008_bb0070","first-page":"247","article-title":"Anemia in malignant tumor diseases. II. Tumor-induced loss of transferrin as a cause of the development of anemia based on a rat model","volume":"28","author":"Aulbert","year":"1989","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.ijcard.2016.05.008_bb0075","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1172\/JCI116897","article-title":"Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model","volume":"92","author":"Costelli","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijcard.2016.05.008_bb0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s13539-013-0110-1","article-title":"Longitudinal changes in total body creatine pool size and skeletal muscle mass using the d-creatine dilution method","volume":"4","author":"Stimpson","year":"2013","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2016.05.008_bb0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijcard.2008.06.094","article-title":"No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure","volume":"137","author":"Akashi","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.05.008_bb0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s13539-011-0044-4","article-title":"Ursodeoxycholic acid treatment in a rat model of cancer cachexia","volume":"3","author":"Tschirner","year":"2012","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2016.05.008_bb0095","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1079\/PAR2004358","article-title":"The role of ubiquitin-proteasome-dependent proteolysis in the remodeling of skeletal muscle","volume":"63","author":"Taillandier","year":"2004","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.ijcard.2016.05.008_bb0100","first-page":"2771","article-title":"Chemotherapy inhibits skeletal muscle ubiquitin-proteasome-dependent proteolysis","volume":"62","author":"Tilignac","year":"2002","journal-title":"Cancer Res."},{"issue":"2010","key":"10.1016\/j.ijcard.2016.05.008_bb0105","first-page":"1155","article-title":"Activity level, apoptosis, and development of cachexia in ApcMin\/+ mice","volume":"109","author":"Baltgalvis","year":"1985","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ijcard.2016.05.008_bb0110","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3892\/etm.2011.260","article-title":"Formoterol and cancer muscle wasting in rats: effects on muscle force and total physical activity","volume":"2","author":"Busquets","year":"2011","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ijcard.2016.05.008_bb0115","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ijcard.2016.05.008_bb0120","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cardiores.2006.06.003","article-title":"Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure","volume":"71","author":"Li","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2016.05.008_bb0125","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0899-9007(97)00185-8","article-title":"Cytokines and cachexia","volume":"13","author":"Matthys","year":"1997","journal-title":"Nutrition"},{"key":"10.1016\/j.ijcard.2016.05.008_bb0130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0167-5273(02)00244-9","article-title":"Cytokines, apoptosis and cachexia: the potential for TNF antagonism","volume":"85","author":"Sharma","year":"2002","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.05.008_bb0135","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cyto.2005.10.002","article-title":"Erythropoietin attenuates cachectic events and decreases production of interleukin-6, a cachexia-inducing cytokine","volume":"32","author":"Kanzaki","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.ijcard.2016.05.008_bb0140","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/cncr.11616","article-title":"Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy","volume":"98","author":"Shasha","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ijcard.2016.05.008_bb0145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/1073858403259187","article-title":"Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go?","volume":"10","author":"Grasso","year":"2004","journal-title":"Neuroscientist"},{"key":"10.1016\/j.ijcard.2016.05.008_bb0150","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.ki.5001546","article-title":"Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise","volume":"70","author":"Brines","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.ijcard.2016.05.008_bb0155","doi-asserted-by":"crossref","first-page":"14907","DOI":"10.1073\/pnas.0406491101","article-title":"Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor","volume":"101","author":"Brines","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijcard.2016.05.008_bb0160","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2796.2008.02024.x","article-title":"Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response","volume":"264","author":"Brines","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.05.008_bb0165","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10557-005-3189-6","article-title":"Cardioprotection by recombinant human erythropoietin following acute experimental myocardial infarction: dose response and therapeutic window","volume":"19","author":"Moon","year":"2005","journal-title":"Cardiovasc. Drugs Ther."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731630910X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731630910X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T21:51:39Z","timestamp":1536702699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752731630910X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":33,"alternative-id":["S016752731630910X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.05.008","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erythropoietin improves cardiac wasting and outcomes in a rat model of liver cancer cachexia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}